DBTX insider filings

Decibel Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-09-25. Screen DBTX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for DBTX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Decibel Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2023-09-254Trask Anna — Chief People OfficerDisposition to issuer (D): 106,864 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 52,500 (derivative) · Disposition to issuer (D): 137,302 (derivative)EDGAR
2023-09-254Carson William H. — DirectorDisposition to issuer (D): 5,000 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR
2023-09-254Lee John Jui-Jen — Chief Development OfficerDisposition to issuer (D): 147,144 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 52,500 (derivative) · Disposition to issuer (D): 232,003 (derivative)EDGAR
2023-09-254FINGER ALISON CECILY — DirectorDisposition to issuer (D): 5,000 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR
2023-09-254Nochur Sara — DirectorDisposition to issuer (D): 5,000 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR
2023-09-254Kapusta Matthew C — DirectorDisposition to issuer (D): 10,000 · Disposition to issuer (D): 10,000 (derivative)EDGAR
2023-09-254Reid Laurence — See Remarks, DirectorDisposition to issuer (D): 220,849 · Disposition to issuer (D): 187,500 (derivative) · Disposition to issuer (D): 72,000 (derivative) · Disposition to issuer (D): 1,072,539 (derivative)EDGAR
2023-09-254MCLAUGHLIN KEVIN F — DirectorDisposition to issuer (D): 5,000 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 5,000 (derivative)EDGAR
2023-06-144Nochur Sara — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0EDGAR
2023-06-144Carson William H. — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0EDGAR
2023-06-144FINGER ALISON CECILY — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0EDGAR
2023-06-144MCLAUGHLIN KEVIN F — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0EDGAR
2023-03-214Kapusta Matthew C — DirectorGrant/award (A): 10,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2023-03-174Reid Laurence — See Remarks, DirectorGrant/award (A): 195,000 @ $0 · Grant/award (A): 72,000 (derivative) @ $0EDGAR
2023-01-304Trask Anna — Chief People OfficerGrant/award (A): 105,000 @ $0 · Grant/award (A): 45,000 (derivative) @ $0EDGAR
2023-01-304Lee John Jui-Jen — Chief Development OfficerGrant/award (A): 120,000 @ $0 · Grant/award (A): 45,000 (derivative) @ $0EDGAR
2022-10-124MCLAUGHLIN KEVIN F — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-214FINGER ALISON CECILY — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2022-06-214Carson William H. — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2022-06-214Nochur Sara — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2022-06-214Exter Neil — Director, 10% ownerGrant/award (A): 10,000 (derivative) @ $0EDGAR
2022-06-214Thompson Peter A. — Director, 10% ownerGrant/award (A): 10,000 (derivative) @ $0EDGAR
2022-02-284Trask Anna — See RemarksGrant/award (A): 52,500 (derivative) @ $0EDGAR
2022-02-284Lee John Jui-Jen — Chief Development OfficerGrant/award (A): 52,500 (derivative) @ $0EDGAR
2022-02-284Leiderman Elisabeth — Chief Financial OfficerGrant/award (A): 52,500 (derivative) @ $0EDGAR
2022-02-284Reid Laurence — See Remarks, DirectorGrant/award (A): 187,500 (derivative) @ $0EDGAR
2022-01-044Trask Anna — See RemarksSale (S): 1 @ $5.04 · Sale (S): 377 @ $5.03EDGAR
2021-12-064Trask Anna — See RemarksSale (S): 4,913 @ $6.37 · Sale (S): 378 @ $6.34EDGAR
2021-12-064Nochur Sara — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-12-064FINGER ALISON CECILY — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-11-044Trask Anna — See RemarksSale (S): 378 @ $8.34EDGAR
2021-11-034Trask Anna — SEE REMARKSSale (S): 4,913 @ $8.31EDGAR
2021-10-154Trask Anna — See RemarksSale (S): 5,364 @ $7.55EDGAR
2021-09-174Reid Laurence — President and Chief Executive, DirectorPurchase (P): 10,000 @ $7.64EDGAR
2021-08-184Hu Cynthia W. — General CounselGrant/award (A): 150,000 (derivative) @ $0EDGAR
2021-06-034Carson William H. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-03-084Schroder Adveq Technology IX S.C.S. — 10% owner
Schroder Adveq Management Luxembourg Sarl — 10% owner
Schroder Adveq cPl Global 2017 - 2019 C.V. — 10% owner
Schroder Adveq cPl Global Management III L.P. — 10% owner
Conversion (C): 524,328 · Conversion (C): 524,328 · Conversion (C): 6,625,001 (derivative) · Conversion (C): 6,625,001 (derivative)EDGAR
2021-02-194Foy Matthew — Director, 10% ownerConversion (C): 458,487 · Conversion (C): 247,324 · Conversion (C): 327,852 · Purchase (P): 150,000 @ $18 · Conversion (C): 7,119,852 (derivative) @ $0 · Conversion (C): 3,125,000 (derivative) @ $0 · +1 moreEDGAR
2021-02-194Exter Neil — Director, 10% ownerConversion (C): 2,938,945 · Conversion (C): 98,929 · Conversion (C): 54,642 · Conversion (C): 45,638,882 (derivative) @ $0 · Conversion (C): 1,250,000 (derivative) @ $0 · Conversion (C): 289,603 (derivative) @ $0EDGAR
2021-02-194Casdin Partners Master Fund, L.P. — 10% ownerConversion (C): 546,421 · Purchase (P): 575,000 @ $18 · Conversion (C): 2,896,032 (derivative) @ $0EDGAR
2021-02-194Thompson Peter A. — Director, 10% ownerConversion (C): 2,732,106 · Conversion (C): 327,852 · Conversion (C): 218,568 · Purchase (P): 1,111,100 @ $18 · Purchase (P): 555,566 @ $18 · Conversion (C): 14,480,162 (derivative) @ $0 · +2 moreEDGAR
2021-02-194GLAXOSMITHKLINE PLC — DirectorConversion (C): 458,487 · Conversion (C): 247,324 · Conversion (C): 327,852 · Purchase (P): 150,000 @ $18 · Conversion (C): 7,119,850 (derivative) · Conversion (C): 3,125,000 (derivative) · +1 moreEDGAR
2021-02-194ORBIMED ADVISORS LLC — Director, 10% owner
OrbiMed Capital GP VIII LLC — Director, 10% owner
OrbiMed Genesis GP LLC — Director, 10% owner
ORBIMED CAPITAL LLC — Director, 10% owner
Conversion (C): 2,732,106 · Conversion (C): 327,852 · Conversion (C): 218,568 · Purchase (P): 1,111,100 @ $18 · Purchase (P): 555,566 @ $18 · Conversion (C): 14,480,162 (derivative) @ $0 · +2 moreEDGAR
2021-02-184Longevity Fund 2 LP — 10% ownerConversion (C): 79,143 · Conversion (C): 79,143 (derivative) @ $0EDGAR
2021-02-184REGENERON PHARMACEUTICALS, INC. — 10% ownerConversion (C): 2,097,314 · Conversion (C): 12,500,000 (derivative) @ $0 · Conversion (C): 14,000,000 (derivative) @ $0EDGAR
2021-02-174GV 2019 GP, L.L.C. — 10% owner
GV 2019 GP, L.P. — 10% owner
GV 2019, L.P. — 10% owner
Conversion (C): 819,631 · Conversion (C): 4,344,048 (derivative)EDGAR
2021-02-174GV 2017 GP, L.L.C. — 10% owner
GV 2017 GP, L.P. — 10% owner
GV 2017, L.P. — 10% owner
Conversion (C): 494,649 · Conversion (C): 6,250,000 (derivative)EDGAR
2021-02-174GV 2016 GP, L.L.C. — 10% owner
GV 2016 GP, L.P. — 10% owner
GV 2016, L.P. — 10% owner
Conversion (C): 321,978 · Conversion (C): 5,000,000 (derivative)EDGAR
2021-02-164Thompson Peter A. — Director, 10% ownerGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-02-164POON CHRISTINE A — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR

Recent 8-K events — Decibel Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-09-258-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-08-258-K8.01 — Other EventsEDGAR
2023-08-098-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-06-138-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2023-04-068-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-218-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-03-138-K7.01 — Regulation FD DisclosureEDGAR
2023-01-098-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-10-178-K8.01 — Other EventsEDGAR
2022-10-128-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=DBTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs